{
    "2019-08-09": [
        [
            {
                "time": "2023-07-25",
                "original_text": "Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Q2 Earnings",
                        "Revenues",
                        "Beat Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-07-26",
                "original_text": "Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "AGN",
                        "NVO Earnings",
                        "EU Nod",
                        "SNY",
                        "ABBV Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-07-27",
                "original_text": "Novo Nordisk's new diabetes, obesity drugs lift sales outlook",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "diabetes",
                        "obesity drugs",
                        "sales outlook"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}